The GBM cell lines used in this study express similar panel of stem markers such as nestin, sex-determining region Y(SRY)–box 2 (Sox2), Musashi-1, and cluster of differentiation (CD)44 [38]. The gene discussed is SOX2; the disease is glioblastoma.